MA23429A1 - Novelle forme galenique de derives de 5-nitro imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus-gastro-intestinal. - Google Patents

Novelle forme galenique de derives de 5-nitro imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus-gastro-intestinal.

Info

Publication number
MA23429A1
MA23429A1 MA23756A MA23756A MA23429A1 MA 23429 A1 MA23429 A1 MA 23429A1 MA 23756 A MA23756 A MA 23756A MA 23756 A MA23756 A MA 23756A MA 23429 A1 MA23429 A1 MA 23429A1
Authority
MA
Morocco
Prior art keywords
gastrointestinal
tractus
parasitosis
infections
whole
Prior art date
Application number
MA23756A
Other languages
English (en)
Inventor
Gerard Leduc
Patrice Debregeas
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/fr
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of MA23429A1 publication Critical patent/MA23429A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA23756A 1994-01-14 1995-01-13 Novelle forme galenique de derives de 5-nitro imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus-gastro-intestinal. MA23429A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (fr) 1994-01-14 1994-01-14 Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.

Publications (1)

Publication Number Publication Date
MA23429A1 true MA23429A1 (fr) 1995-10-01

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23756A MA23429A1 (fr) 1994-01-14 1995-01-13 Novelle forme galenique de derives de 5-nitro imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus-gastro-intestinal.

Country Status (19)

Country Link
JP (1) JPH09507499A (fr)
KR (1) KR100320140B1 (fr)
CN (1) CN1088357C (fr)
AT (1) ATE187068T1 (fr)
AU (1) AU705570B2 (fr)
BR (1) BR9506507A (fr)
CZ (1) CZ286080B6 (fr)
DE (1) DE69513632T2 (fr)
DK (1) DK0739201T3 (fr)
ES (1) ES2139883T3 (fr)
MA (1) MA23429A1 (fr)
MX (1) MX9602772A (fr)
NZ (1) NZ279238A (fr)
OA (1) OA10583A (fr)
PL (1) PL178424B1 (fr)
PT (1) PT739201E (fr)
RU (1) RU2152212C1 (fr)
SK (1) SK282066B6 (fr)
UA (1) UA28031C2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
CA2959414C (fr) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole utilise dans le traitement d'une vaginose bacterienne

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
AU7909691A (en) * 1990-05-14 1991-12-10 Gary R. Jernberg Surgical implant and method incorporating chemotherapeutic agents

Also Published As

Publication number Publication date
BR9506507A (pt) 1997-09-09
DE69513632D1 (de) 2000-01-05
PT739201E (pt) 2000-05-31
OA10583A (en) 2002-07-10
DK0739201T3 (da) 2000-05-01
ES2139883T3 (es) 2000-02-16
KR100320140B1 (ko) 2002-07-02
CN1088357C (zh) 2002-07-31
RU2152212C1 (ru) 2000-07-10
SK282066B6 (sk) 2001-10-08
PL178424B1 (pl) 2000-04-28
AU705570B2 (en) 1999-05-27
CZ286080B6 (cs) 2000-01-12
SK91496A3 (en) 1996-12-04
PL315530A1 (en) 1996-11-12
JPH09507499A (ja) 1997-07-29
ATE187068T1 (de) 1999-12-15
DE69513632T2 (de) 2000-04-06
CN1138826A (zh) 1996-12-25
NZ279238A (en) 1998-03-25
AU1580395A (en) 1995-08-01
CZ205596A3 (en) 1996-10-16
MX9602772A (es) 1997-05-31
UA28031C2 (uk) 2000-10-16

Similar Documents

Publication Publication Date Title
TWI265808B (en) Valdecoxib compositions
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
ATE486840T1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
HUP0102033A2 (hu) PEG IFN-alfa és ribavirin felhasználása krónikus hepatitis C kezelésére
DE69905368D1 (en) Oxydiertes thymosin beta 4
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
SV2002000235A (es) Composiciones farmaceuticas que comprenden valdecoxib
MA26777A1 (fr) Inhibiteurs d'aminotransferase dependante d'aminoacide en chaine ramifiee et leur usage dans le traitement de la retinopathie diabetique.
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
MA23429A1 (fr) Novelle forme galenique de derives de 5-nitro imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus-gastro-intestinal.
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
EA200000909A1 (ru) ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА
TR199802200A2 (xx) S�lfonamid s�bstit�e edilmi� benzopiran t�revleri, �retilme y�ntemi.
DZ3320A1 (fr) Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine
RU99127647A (ru) Средство для лечения сексуальных дисфункций у мужчин
WO1999020259A3 (fr) Compositions contenant thiamphenicol et diclofenac
FR2720944B1 (fr) Composition thérapeutique ou diététique sous forme de gel médicamenteux pour l'administration à des animaux de compagnie.
FR2802101B1 (fr) Association de cymemazine et d'un neuroleptique atypique
TR199701605A2 (xx) S�lfonamid-substit�e edilmi� bile�ikler
GB9209599D0 (en) Novel therapy for the treatment of parkinsons disease
FR2709964B1 (fr) Compositions pharmaceutiques antivirales proposées dans le traitement du SIDA et de l'Herpès.
TNSN00242A1 (fr) Valdecoxib compositions
DE60040856D1 (de) Lactalbumin zur kurativen Behandlung von Magengeschwüren
ES2150400A6 (es) Una composicion para el tratamiento de desordenes ulcerosos del tracto gastrointestinal.